CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Open Lable Clinical Study Efficacy and Safety of the Holistic Treatment for Young Patients With High-Risk Multiple Myeloma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04008888
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:14.445586+00:00
Published At: 2019-07-05T00:00:00+00:00
Record Updated At: 2019-07-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Multiple Myeloma", "Plasma Cell Leukemia", "Extramedullary Plasmacytoma", "Loss of Chromosome 17p", "t(14;16)", "t(4;14)", "T(14;20)", "1Q21 Amplification", "Complex Karyotype"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-07-05"
protocolSection.identificationModule.nctId: "NCT04008888"
protocolSection.identificationModule.officialTitle: "Phase II Open Lable Clinical Study Efficacy and Safety of the Holistic Treatment for Young Patients With High-Risk Multiple Myeloma"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.